|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-6-2
|
|
pubmed:abstractText |
Cancer of the urinary bladder is a common malignant disease in the western countries. The majority of patients presents with superficial tumors with a high recurrence frequency, a minor fraction of these patients experience disease progression to a muscle invasive stage. No clinical useful molecular markers exist to identify patients showing later disease progression. The purpose of this study was to identify markers of disease progression using full-genome expression analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4029-36
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15930337-Cluster Analysis,
pubmed-meshheading:15930337-Disease Progression,
pubmed-meshheading:15930337-Expressed Sequence Tags,
pubmed-meshheading:15930337-Gene Expression Profiling,
pubmed-meshheading:15930337-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15930337-Genome, Human,
pubmed-meshheading:15930337-Humans,
pubmed-meshheading:15930337-Neoplasm Invasiveness,
pubmed-meshheading:15930337-Neoplasm Staging,
pubmed-meshheading:15930337-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:15930337-Prognosis,
pubmed-meshheading:15930337-Urinary Bladder Neoplasms
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A molecular signature in superficial bladder carcinoma predicts clinical outcome.
|
|
pubmed:affiliation |
Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
